HMOX1 and interstitial lung disease: In the present study, compared to commonly used clinical parameters such as blood biomarkers and HRCT findings, serum HO-1 proved useful for diagnosing the acute exacerbation of ILD and predicting the short-term prognosis of acute exacerbations.